CODX vs KLAC · rev $3.9M vs P/E 55, rev $12.16B
Co-Diagnostics, Inc. Common Stock (CODX) versus KLA Corporation (KLAC) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
KLA Corporation (KLAC) is a semiconductor equipment & materials company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported KLAC revenue for 2025-06-30 was $12.16B. Net income was $4.06B. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
CODX currently screens at market cap $31.4M. KLAC currently screens at market cap $252.01B and trailing P/E 54.7.
Not investment advice. Open the CODX and KLAC stock pages for the full models.
Not investment advice.